跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
FOCLIVIA
Authorized
STANDARD
FOCLIVIA
SEQIRUS UK LIMITED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6df3b5219e89812b
Company
SEQIRUS UK LIMITED
Type
Standard
Approval Details
Approval Id
6df3b5219e89812b
Drug Approval Canada Name
FOCLIVIA
Product Name
FOCLIVIA
Status
Approved
Status Date
2021-01-07
Din
02510561
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Intramuscular
Schedule
Schedule D
Ahfs
80:12.00
Atc Original
J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Atc Name
j 07 bb 02
Aig Number
0162701001
Company Name
SEQIRUS UK LIMITED
Company Address
29 Market Street, Level 3, Maidenhead, Berkshire, United Kingdom, SL6 8AA
Company Detail Path
/organization/seqirus-uk-limited
Company Information
Pharmaceutical Company Name
SEQIRUS UK LIMITED
Country Name
United Kingdom
City Name
maidenhead,country_gb
Address
Point
Active Ingredients
HAEMAGGLUTININ-STRAIN A (H5N1)
7.5 MCG / 0.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6df3b5219e89812b
Type
Standard
Back to Health Canada Approvals
FOCLIVIA - Health Canada Drug Approval Details